These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20420580)

  • 21. Upregulation of casein kinase 1epsilon in dorsal root ganglia and spinal cord after mouse spinal nerve injury contributes to neuropathic pain.
    Sakurai E; Kurihara T; Kouchi K; Saegusa H; Zong S; Tanabe T
    Mol Pain; 2009 Dec; 5():74. PubMed ID: 20021638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats.
    Ahn DK; Lee SY; Han SR; Ju JS; Yang GY; Lee MK; Youn DH; Bae YC
    Pain; 2009 Nov; 146(1-2):114-20. PubMed ID: 19665300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice.
    López-Serrano C; Santos-Nogueira E; Francos-Quijorna I; Coll-Miró M; Chun J; López-Vales R
    Brain Behav Immun; 2019 Feb; 76():258-267. PubMed ID: 30550929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysophosphatidic acid activates satellite glia cells and Schwann cells.
    Robering JW; Gebhardt L; Wolf K; Kühn H; Kremer AE; Fischer MJM
    Glia; 2019 May; 67(5):999-1012. PubMed ID: 30637823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysophosphatidic acid-induced itch is mediated by signalling of LPA
    Kittaka H; Uchida K; Fukuta N; Tominaga M
    J Physiol; 2017 Apr; 595(8):2681-2698. PubMed ID: 28176353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of LPA1 receptor signaling in the reorganization of spinal input through Abeta-fibers in mice with partial sciatic nerve injury.
    Xie W; Matsumoto M; Chun J; Ueda H
    Mol Pain; 2008 Oct; 4():46. PubMed ID: 18854053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents.
    Murai N; Hiyama H; Kiso T; Sekizawa T; Watabiki T; Oka H; Aoki T
    Neuropharmacology; 2017 Nov; 126():97-107. PubMed ID: 28859883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain.
    Velasco M; O'Sullivan C; Sheridan GK
    Neuropharmacology; 2017 Feb; 113(Pt B):608-617. PubMed ID: 27059127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
    Lin ME; Rivera RR; Chun J
    J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysophosphatidic acid: chemical signature of neuropathic pain.
    Ueda H; Matsunaga H; Olaposi OI; Nagai J
    Biochim Biophys Acta; 2013 Jan; 1831(1):61-73. PubMed ID: 22960381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of Nav1.8 by Lysophosphatidic Acid in the Induction of Bone Cancer Pain.
    Pan HL; Liu BL; Lin W; Zhang YQ
    Neurosci Bull; 2016 Oct; 32(5):445-54. PubMed ID: 27631681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the Nav1.8 ion channel engenders sex-specific responses in lysophosphatidic acid-induced joint neuropathy.
    O'Brien MS; Philpott HTA; McDougall JJ
    Pain; 2019 Jan; 160(1):269-278. PubMed ID: 30211781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain.
    Racz I; Nadal X; Alferink J; Baños JE; Rehnelt J; Martín M; Pintado B; Gutierrez-Adan A; Sanguino E; Manzanares J; Zimmer A; Maldonado R
    J Neurosci; 2008 Nov; 28(46):12125-35. PubMed ID: 19005077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of lysophosphatidic acid-induced pain with clinically relevant neuropathic pain drugs.
    Ogawa K; Takasu K; Shinohara S; Yoneda Y; Kato A
    Eur J Pain; 2012 Aug; 16(7):994-1004. PubMed ID: 22337641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue plasminogen activator in primary afferents induces dorsal horn excitability and pain response after peripheral nerve injury.
    Yamanaka H; Obata K; Fukuoka T; Dai Y; Kobayashi K; Tokunaga A; Noguchi K
    Eur J Neurosci; 2004 Jan; 19(1):93-102. PubMed ID: 14750967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysophosphatidic acid and its receptor LPA
    Srikanth M; Chew WS; Hind T; Lim SM; Hay NWJ; Lee JHM; Rivera R; Chun J; Ong WY; Herr DR
    Eur J Pharmacol; 2018 Dec; 841():49-56. PubMed ID: 30321532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential galanin upregulation in dorsal root ganglia and spinal cord after graded single ligature nerve constriction of the rat sciatic nerve.
    Coronel MF; Brumovsky PR; Hökfelt T; Villar MJ
    J Chem Neuroanat; 2008 Jan; 35(1):94-100. PubMed ID: 17693056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelin-related gene silencing mediated by LPA
    Tsukahara R; Ueda H
    J Pharmacol Sci; 2016 Oct; 132(2):162-165. PubMed ID: 27681370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The sensitization of peripheral C-fibers to lysophosphatidic acid in bone cancer pain.
    Zhao J; Pan HL; Li TT; Zhang YQ; Wei JY; Zhao ZQ
    Life Sci; 2010 Jul; 87(3-4):120-5. PubMed ID: 20553953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of Homer1b/c and Shank1a in the post-synaptic density of spinal dorsal horn neurons are associated with neuropathic pain in rats.
    Miletic G; Miyabe T; Gebhardt KJ; Miletic V
    Neurosci Lett; 2005 Oct; 386(3):189-93. PubMed ID: 16002212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.